 Trilostane was approved in the United States in 2008 for the treatment of Cushing's disease (hyperadrenocorticism) in dogs under the brand name Vetoryl.It was available by prescription in the United Kingdom for dogs under the Vetoryl brand name for some time before it was approved in the United States.The drug is also used to treat the skin disorder Alopecia X in dogs.